We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$91.2M
(+26%)
Cap. Flow
+$74.5M
Cap. Flow
% of AUM
16.9%
Top 10 Holdings %
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$15.4M |
| 2 |
Stellantis
STLA
|
+$9.9M |
| 3 |
Alcon
ALC
|
+$7.77M |
| 4 |
Amazon
AMZN
|
+$6.64M |
| 5 |
Ferrari
RACE
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$8.02M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$6.88M |
| 3 |
Linde
LIN
|
+$5.74M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$5.13M |
| 5 |
iShares MSCI Turkey ETF
TUR
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.26% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.86% |
| 4 | Healthcare | 10.91% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Broadcom
AVGO
$1.82T
| $1.29M | 0.29% |
26,610
+25,790
| +3,145% | +$1.2M |
|
77
Align Technology
ALGN
$12B
| $1.28M | 0.29% |
+1,998
| New | +$1.18M |
|
78
Chubb
CB
$140B
| $1.28M | 0.29% |
7,831
+419
| +6% | +$69.4K |
|
79
Mastercard
MA
$477B
| $1.24M | 0.28% |
3,236
+1,522
| +89% | +$566K |
|
80
Pfizer
PFE
$140B
| $1.24M | 0.28% |
31,209
-11,701
| -27% | -$455K |
|
81
Advanced Micro Devices
AMD
$851B
| $1.23M | 0.28% |
+13,656
| New | +$1.1M |
|
82
Dow Inc
DOW
$21.6B
| $1.23M | 0.28% |
+19,621
| New | +$1.3M |
|
83
Caterpillar
CAT
$409B
| $1.23M | 0.28% |
5,711
-388
| -6% | -$89.6K |
|
84
Analog Devices
ADI
$181B
| $1.22M | 0.28% |
+7,301
| New | +$1.17M |
|
85
Bristol-Myers Squibb
BMY
$127B
| $1.18M | 0.27% |
17,539
-1,165
| -6% | -$76K |
|
86
Welltower
WELL
$178B
| $1.11M | 0.25% |
12,786
-2,519
| -16% | -$193K |
|
87
State Street SPDR S&P Bank ETF
KBE
$1.64B
| $1.09M | 0.25% |
21,917
+5,362
| +32% | +$286K |
|
|
PING
88
DELISTED
Ping Identity Holding Corp.
PING
| $1.07M | 0.24% |
46,060
+1,842
| +4% | +$43.4K |
|
89
PepsiCo
PEP
$186B
| $1.07M | 0.24% |
6,972
+331
| +5% | +$48.2K |
|
|
XYZ
90
Block Inc
XYZ
$45.9B
| $1.06M | 0.24% |
4,386
+895
| +26% | +$208K |
|
|
AQUA
91
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.04M | 0.24% |
32,634
+8,980
| +38% | +$270K |
|
92
Vanguard Value ETF
VTV
$189B
| $1.04M | 0.24% |
7,528
+3,655
| +94% | +$502K |
|
|
PIPP.U
93
DELISTED
Pine Island Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
PIPP.U
| $1.02M | 0.23% |
100,395
| – | – |
|
|
NOACU
94
DELISTED
Natural Order Acquisition Corp. Unit
NOACU
| $988K | 0.22% |
95,000
| – | – |
|
95
Sea Limited
SE
$61.2B
| $984K | 0.22% |
3,503
-6
| -0.2% | -$1.52K |
|
96
Eagle Materials
EXP
$6.6B
| $959K | 0.22% |
6,937
+6,352
| +1,086% | +$913K |
|
|
AMED
97
DELISTED
Amedisys
AMED
| $958K | 0.22% |
+3,625
| New | +$951K |
|
98
Vulcan Materials
VMC
$36.3B
| $955K | 0.22% |
5,503
+5,122
| +1,344% | +$916K |
|
99
Clean Harbors
CLH
$16.1B
| $925K | 0.21% |
+10,030
| New | +$911K |
|
100
Philip Morris
PM
$301B
| $894K | 0.2% |
9,153
-911
| -9% | -$87.4K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2021 Portfolio in Review
As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.
- Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
- Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
- Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
- Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
- Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
- Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
- Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.
Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.